Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00309114 · ClinicalTrials.gov registry record · NA
Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)
A NA study of Urinary Tract Infections, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 5
- Study locations
NCT00309114 is a NA study of Urinary Tract Infections that has completed, run by Baylor College of Medicine. The registered enrollment target is 65 participants, below the 456-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 3 states.
The verdict
NCT00309114, a NA study of Urinary Tract Infections, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 5
- Study locations
Study Summary
Urinary tract infection (UTI) is the most common infection in patients with spinal cord injury (SCI) and is linked to major undesired results or complications including death. The bladder of SCI patients, especially those with indwelling catheters, is usually colonized by bacteria, some of which do and others which do not cause symptoms of UTI. Bacteria that do not cause symptoms are often called benign colonizers and are often left untreated because they may provide some protection against infection with more harmful bacteria. This idea of using benign bacteria to prevent infections with symptoms is called bacterial interference. A prototype strain, Escherichia coli 83972, was shown to begin and continue for extended periods of time non symptom causing colonization of the human bladder and to hold back symptom causing infections of the neurogenic bladder. Data from pilot studies at two medical centers indicated that bacterial interference might be a useful therapy for reducing the rate or frequency of UTI in SCI patients. Because almost all SCI patients have a UTI at some time, and also the large costs of treating this infection, studying the impact of bladder colonization with E. coli 83972 on the rate of symptom causing UTI has an amazing potential for improving the quality of life of SCI patients and decreasing the cost of health care. Like with other preventive plans such as vaccination, for instance, it is important to explore the effectiveness of this new preventive approach. The project is a prospective, randomized, double blind, multi-center study that deals with specific pieces of bacterial interference in SCI patients. HYPOTHESES: Placing non symptom causing bacteria (E. coli 83972) into SCI patients' bladders reduces the rate of symptom causing UTI. A. SPECIFIC AIM: Determine how bladder colonization with E. coli 83972 or similar bacteria affects the rate of symptom causing urinary tract infections in a large group of SCI and Spina Bifida patients by c
Conditions Studied
Interventions
- PROCEDURE bacterial interference
Study Locations (5)
Texas
- UT Southwestern - Dallas
- Michael E Debakey VA Medical Center - Houston
- The Institute for Rehabilitation and Research (TIRR) - Houston
Georgia
- Shepherd Center - Atlanta
Illinois
- Rehab Institute Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2004-02 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00309114
The ClinicalTrials.gov registry entry for NCT00309114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 456-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (86% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Tract Infections appearing as the primary indexed condition, and to 1 intervention - of which bacterial interference is the first listed.
NCT00309114 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Texas, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT00309114 about?
NCT00309114 is a clinical study titled "Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)". Urinary tract infection (UTI) is the most common infection in patients with spinal cord injury (SCI) and is linked to major undesired results or complications including death. The bladder of SCI patients, especially those with indwelling catheters, is usually colonized by bacteria, some of which do ...
What is the current status of trial NCT00309114?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2004-02. Estimated completion is 2009-11.
What conditions does trial NCT00309114 study?
This clinical trial studies the following conditions: Urinary Tract Infections.
What interventions are being tested in trial NCT00309114?
The interventions under investigation include: bacterial interference (PROCEDURE).
Who is sponsoring clinical trial NCT00309114?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00309114 being conducted?
This trial has 5 study locations across Georgia, Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Double Voiding and Post-transplant UTI
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.